Dr. Marc Hedrick | President and Chief Executive Officer |
Desiree Smith | Corporate Controller and Principal Accounting Officer |
Emad Samad | WBB |
Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Investor Conference Call. At this time, all participants have been placed in a listen-only mode and the floor will be open for questions following the presentation. [Operator Instructions]
Before we begin, we want to advise you that over the course of the call and question-and-answer session, forward-looking statements will be made regarding events, trends, business prospects and financial performance, which may affect Plus Therapeutics future operating results and financial position.